| Citation: | HAN Zhengxiang, WEI Yanhong, ZHANG Yuming, GENG Jie, ZHANG Jie, DU Xiuping. Inhibitory Effect of Celecoxib on Triple-negative Breast Cancer Stem Cells in vitro[J]. Cancer Research on Prevention and Treatment, 2013, 40(12): 1119-1122. DOI: 10.3971/j.issn.1000-8578.2013.12.003 |
| [1] |
Gierach GL, Burke A, Anderson WF. Epidemiology of triple negative breast cancers[J]. Breast Dis,2010,32(1-2):5-24.
|
| [2] |
Gelmon K, Dent R, Mackey JR, et al. Targeting triple-negative breast cancer: optimising therapeutic outcomes[J]. Ann Oncol,201 2, 23(9):2223-34.
|
| [3] |
Xie GZ, Zhan JF, Sun AM, et al. Suspension sphere culture combined with irradiation for purifying breast cancer stem cells[J]. Shi Yong Yi Xue Za Zhi, 2010, 26(11): 1893-6. [谢国柱, 詹军芳, 孙爱民, 等. 辐射与悬浮球培养联合纯化乳腺癌干细胞 [J] 实用医学杂志, 2010, 26(11): 1893-6.]
|
| [4] |
Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature,2001,414(6859):105-11.
|
| [5] |
Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci U S A,2003,100(7):3983-8.
|
| [6] |
Jana D, Sarkar DK, Maji A, et al. Can cyclo-oxygenase-2 be a useful prognostic and risk stratification marker in breast cancer?[J]. J Indian Med Assoc,2012,110(7):429-33.
|
| [1] | Wu Shisheng, Shao Lihua, LI Shangr, Zhang Fei, Xie Hong, Zhang Chunxiu, Liu Guiping. Correlation of MMP-9 and MMP-2 Gene SNPs with Hepatocellular Carcinoma Invasion and Metastasis[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 683-686. DOI: 10.3971/j.issn.1000-8578.2012.06.017 |
| [2] | Chen Shouren, Wang Zhanxiang, Shen Shanghang, Tan Guowei, Liu Xiyao, Zhu Hongwei. miR-126 Inhibits Invasion of Human Brain Glioma Cells by Decreasing MMP-2[J]. Cancer Research on Prevention and Treatment, 2012, 39(03): 264-266. DOI: 10.3971/j.issn.1000-8578.2012.03.005 |
| [3] | ZHANG Jun-xiang, LIU Zhang-suo, WANG Jian-jun. Expression and Significance of ANGPTL3,MMP-2 and MMP-9 in Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(09): 1028-1030. DOI: 10.3971/j.issn.1000-8578.2011.09.013 |
| [4] | XUAN Xiao-yan, LI Shan-shan, ZHENG Xian-zhao, LI Na, WANG Feng. Effect of Silencing STAT3 by siRNA on Expression of MMP-2 in Esophageal Carcinoma Cell Line EC-1[J]. Cancer Research on Prevention and Treatment, 2010, 37(04): 395-397. DOI: 10.3971/j.issn.1000-8578.2010.04.007 |
| [5] | ZHAO Bin-bin, ZHU Yun-kui, LI Ji-dong, WANG Shu, LIU Wei. Influence of Tumor-host Cooperation in Regulating MMP-2 and MMP-9 Expression in Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2009, 36(09): 737-740. DOI: 10.3971/j.issn.1000-8578.2009.09.005 |
| [6] | WAN Zhen-ling, HU Zhong-liang, LIU Bao-an. TGFβ1 Upregulates Expression of MMP-2 and MMP-9 through ERK Signaling Pathway in Gastric Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2009, 36(02): 91-94. DOI: 10.3971/j.issn.1000-8578.2009.02.003 |
| [7] | LUO Hong-bo, LIU Xiu-heng, CHEN Zhimin, ZHANG De-Ling. Immunohistochemical Study of COX-2 and MMP-2 in Human Renal Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2005, 32(06): 354-346. DOI: 10.3971/j.issn.1000-8578.2783 |
| [8] | ZHOU Hong-yan, DIAO Lu-ming, CHEN Ying, DENG Hao, LIU Li-jiang. Relationship of the Expression of MMP-2 、MMP-9 、TIMP-1 with Lymph Node Metastasis and Survival Time in Gastric Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2005, 32(05): 274-275. DOI: 10.3971/j.issn.1000-8578.1272 |
| [9] | CAO Ge, SHEN Zhi-xiang, HUANG Jie-an, et al. Correlation between expression of CD44v6, MMP-2 and nm23-H1 in colorectal carcinoma and its clinicalopathological characters[J]. Cancer Research on Prevention and Treatment, 2002, 29(01): 53-56. DOI: 10.3971/j.issn.1000-8578.126 |
| [10] | ZHAO Yue-wu, KONG Ling-fei, TANG Hua, et al. Study on Relationship between Activity of MMP-2(72KD),MMP-9(92KD) and Invasion Metastasis of Human Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2000, 27(05): 370-372. DOI: 10.3971/j.issn.1000-8578.3400 |